Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A
The BioMedWire Podcast · [email protected]
February 23, 202618m 57s
Audio is streamed directly from the publisher (mcdn.podbean.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.